BlackRock Fund Advisors - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 184 filers reported holding NEKTAR THERAPEUTICS in Q2 2015. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q4 2016$169,862,000
-9.9%
13,843,692
+26.2%
0.03%
-20.5%
Q3 2016$188,481,000
+29.6%
10,970,974
+7.3%
0.04%
+21.9%
Q2 2016$145,452,000
+5.5%
10,221,478
+1.9%
0.03%0.0%
Q1 2016$137,905,000
-17.0%
10,029,475
+1.7%
0.03%
-15.8%
Q4 2015$166,103,000
+54.8%
9,857,716
+0.7%
0.04%
+35.7%
Q3 2015$107,276,000
-7.7%
9,787,913
+5.4%
0.03%0.0%
Q2 2015$116,205,000
+117.0%
9,288,975
+90.8%
0.03%
+115.4%
Q1 2015$53,562,000
-27.0%
4,869,231
+2.9%
0.01%
-27.8%
Q4 2014$73,367,000
+41.2%
4,733,348
+9.9%
0.02%
+20.0%
Q3 2014$51,975,000
-9.5%
4,306,099
-3.9%
0.02%
-6.2%
Q2 2014$57,442,000
-2.6%
4,480,672
-7.9%
0.02%
-5.9%
Q1 2014$58,947,000
+19.9%
4,863,573
+12.3%
0.02%
+13.3%
Q4 2013$49,165,000
+7.5%
4,331,732
-1.1%
0.02%0.0%
Q3 2013$45,752,000
+4.4%
4,380,285
+15.4%
0.02%
-6.2%
Q2 2013$43,840,0003,795,6540.02%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q2 2015
NameSharesValueWeighting ↓
Strong Tower Advisory Services 404,972$6,913,0004.02%
GREAT POINT PARTNERS LLC 504,691$9,064,0002.11%
Camber Capital Management LP 3,750,000$67,350,0002.07%
ACT CAPITAL MANAGEMENT, LLC 161,500$2,901,0001.50%
Rhenman & Partners Asset Management AB 950,000$17,062,0001.20%
MAVERICK CAPITAL LTD 5,838,426$104,858,0001.06%
Birchview Capital, LP 72,000$1,293,0000.88%
Bellevue Group AG 4,594,656$82,519,0000.84%
CM Management, LLC 50,000$898,0000.67%
Duquesne Family Office 1,000,000$17,960,0000.58%
View complete list of NEKTAR THERAPEUTICS shareholders